Immutep to Present Positive Phase I Data for IMP761 at EULAR
04 Jun 2026 //
GLOBENEWSWIRE
Immutep Releases Q3 FY26 Activities Report
30 Apr 2026 //
GLOBENEWSWIRE
Immutep Reports Phase I LAG-3 Progress in Autoimmune Diseases
19 Mar 2026 //
GLOBENEWSWIRE

Market Place
Sourcing Support